2020
DOI: 10.1080/21681805.2020.1806354
|View full text |Cite
|
Sign up to set email alerts
|

Histopathological re-evaluations of biopsies in prostate cancer: a nationwide observational study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 33 publications
0
6
0
Order By: Relevance
“…Previous studies have already established interobserver variability in prostate cancer grading [7,8,10,12]. Allsbrook et al found a moderate kappa of 0.435 for the Gleason grading system, and Ozkan et al established considerable interobserver variability after the ISUP 2014 alterations (concordance of 51.7% and kappa = 0.39 for ISUP Grade) [7,10,12].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Previous studies have already established interobserver variability in prostate cancer grading [7,8,10,12]. Allsbrook et al found a moderate kappa of 0.435 for the Gleason grading system, and Ozkan et al established considerable interobserver variability after the ISUP 2014 alterations (concordance of 51.7% and kappa = 0.39 for ISUP Grade) [7,10,12].…”
Section: Discussionmentioning
confidence: 99%
“…Santvoort et al studied all revised pathology reports in The Netherlands from October 2015 until April 2016. They found that 25% of reports were up-or downgraded on revision, but the number of patients with re-evaluations was low (172 versus 5042 cases without re-evaluation, 3% and 97%, respectively) [8].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In Dutch PCa practice, re-evaluations are rarely performed, as only 1262 reports (<4% of all reports, data not shown) were marked as a re-evaluation report. This has not improved after 2015–2016, as in the ProZIB cohort, 3% of all patients with PCa received a re-evaluation 28. Especially for patients for whom grade could be the determining factor, a re-evaluation could have implications for both treatment strategy and patient outcome.…”
Section: Discussionmentioning
confidence: 99%